C-reactive protein (CRP) as a prognostic biomarker in patients with bladder cancer: A meta-analysis. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not ...

Urothelial carcinoma (UC), which can involve the urethra, bladder, and upper tracts is the sixth most commonly diagnosed cancer in Western countries. 1 Radical cystectomy (RC) with pelvic lymph node ...

or on the link below. Urothelial cancer (UC) is the most common histology seen in bladder tumors. The 2022 WHO classification of urinary tract tumors includes a list of less common subtypes (formerly ...

In a phase 2 trial of nonurothelial MIBC, half of patients receiving neoadjuvant chemoimmunotherapy showed no residual cancer at the time of surgery. The single-center, phase 2 trial included 17 ...

Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...

Stage 2 bladder cancer is an advanced bladder cancer stage. It is a muscle-invasive form of bladder cancer, which means the tumor has spread into the muscle layer of the bladder lining. Bladder cancer ...

Surgery for advanced bladder cancer includes transurethral resection of the bladder tumor (TURBT) to remove tumors and cystectomy to remove all or part of the bladder, with the choice depending on the ...

TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional ...

Age can affect bladder cancer survival, with older age typically linking to reduced survival rates. Other factors impacting bladder cancer survival can include the cancer’s stage. Bladder cancer ...

Renal Cell Carcinoma of Variant Histology: New Biologic Understanding Leads to Therapeutic Advances Urothelial cancer (UC) is the most common histology seen in bladder tumors. The 2022 WHO ...